Formulation

Each film-coated tablet contains:
Vildagliptin	50 mg
Metformin HCl	500 mg

Each film-coated tablet contains:
Vildagliptin	50 mg
Metformin HCl	850 mg

Each film-coated tablet contains:
Vildagliptin	50 mg
Metformin HCl	1000 mg

Vildagliptin + Metformin HCl

ProglinMet®

Prescription Drug

Indications

For patients with type 2 diabetes mellitus (T2DM):

as an adjunct to diet and exercise to improve glycemic control in patients whose diabetes is not adequately controlled on metformin hydrochloride or vildagliptin alone or who are already treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets
in combination with a sulfonylurea (SU) (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulfonylurea.
add-on to insulin as an adjunct to diet and exercise to improve glycemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycemic control.
initial therapy in patients with T2DM whose diabetes is not adequately controlled by diet and exercise alone.

Dosage and Administration

For more information on safety, precaution and other information about this product, please see the Product Insert.

Download Product Insert

Please consult your physician and other healthcare providers before taking any prescription medicines found on this site. The contents found on this page are for information purposes only. It should not be construed as a substitute for professional medical advise and should not be relied upon in that regard. You undertake to carefully read all product packaging and labels prior to use.

Caution: Food, Drugs, Devices and Cosmetics Act prohibits dispensing without prescription.